# Matthew Frohn

> Matthew Frohn is a Series A investor at Longwall Venture (Oxford) backing Medical and Biopharma. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Longwall Venture](https://shizune.co/investors/profile/longwall-venture-partners)
- Location: Oxford, United Kingdom
- Total investments: 1
- Last investment: Apr 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/matthew-frohn-7ba2442

Matthew Frohn is a Series A investor at Longwall Venture in Oxford focused on Medical and Biopharma. Dr Matthew Frohn graduated from Oxford Brookes University with a degree in Cell and Molecular Biology followed by a D.Phil in Biochemistry from Oxford University. He worked on research collaborations with Astra Zeneca, and a short research post with a British Biotech subsidiary before joining Oxford Technology Management in 1999, the manager of theOxford Technology VCTs. He is particularly involved with its life science investments.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biopharma | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |

6 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Caristo Diagnostics | Caristo Diagnostics is revolutionizing cardiovascular diagnostics and risk prediction with its advanced, AI-based CT imaging analysis tools. | $16.3M | Series A | Apr 17, 2023 |  |

1 of 1 investments shown.

## Co-investors
- [BGF Ventures](https://shizune.co/investors/profile/bgf-ventures) — VC Fund, 2 deals together
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-sciences-innovation) — VC Fund, 1 deal together
- [Oxford Investment Consultants LLP](https://shizune.co/investors/profile/oxford-technology-and-innovations-fund) — VC Fund, 1 deal together
- [Oxford University Innovation](https://shizune.co/investors/profile/oxford-university-innovation) — VC Fund, 1 deal together

## About Longwall Venture

VC Fund · Harwell, United Kingdom

Longwall Ventures LLP is a venture capital firm specializing in growth capital, early stage, and start-up investments. It targets investing in science including physical science, life science, healthcare, security, media, business software, engineering, and technology companies based in United Kingdom. Longwall Ventures LLP was founded in 2011 andis based in Oxford, United Kingdom.

4 contacts available at Longwall Venture.

| Name | Title | Profile |
| --- | --- | --- |
| David Denny | Partner | https://shizune.co/investors/profile/david-denny |
| Matthew Frohn | Partner | https://shizune.co/investors/profile/matthew-frohn |
| Rebecca Todd | Investment Director | https://shizune.co/investors/profile/rebecca-todd |
| Michael Penington | Partner | https://shizune.co/investors/profile/michael-penington |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Matthew Frohn invest in?

Matthew Frohn invests primarily in Medical, Biopharma and Health Care startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Matthew Frohn last invest?

The most recent investment recorded for Matthew Frohn closed in Apr 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co